Cargando…

Antiviral response in vernal keratoconjunctivitis may be protective against COVID‐19

Detalles Bibliográficos
Autores principales: Leonardi, Andrea, Rosani, Umberto, Cavarzeran, Fabiano, Daull, Philippe, Garrigue, Jean‐Sebastien, Paola, Brun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441822/
https://www.ncbi.nlm.nih.gov/pubmed/34390598
http://dx.doi.org/10.1111/all.15048
_version_ 1783752916244365312
author Leonardi, Andrea
Rosani, Umberto
Cavarzeran, Fabiano
Daull, Philippe
Garrigue, Jean‐Sebastien
Paola, Brun
author_facet Leonardi, Andrea
Rosani, Umberto
Cavarzeran, Fabiano
Daull, Philippe
Garrigue, Jean‐Sebastien
Paola, Brun
author_sort Leonardi, Andrea
collection PubMed
description
format Online
Article
Text
id pubmed-8441822
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-84418222021-09-15 Antiviral response in vernal keratoconjunctivitis may be protective against COVID‐19 Leonardi, Andrea Rosani, Umberto Cavarzeran, Fabiano Daull, Philippe Garrigue, Jean‐Sebastien Paola, Brun Allergy Letters John Wiley and Sons Inc. 2021-08-21 2022-01 /pmc/articles/PMC8441822/ /pubmed/34390598 http://dx.doi.org/10.1111/all.15048 Text en © 2021 The Authors. Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Letters
Leonardi, Andrea
Rosani, Umberto
Cavarzeran, Fabiano
Daull, Philippe
Garrigue, Jean‐Sebastien
Paola, Brun
Antiviral response in vernal keratoconjunctivitis may be protective against COVID‐19
title Antiviral response in vernal keratoconjunctivitis may be protective against COVID‐19
title_full Antiviral response in vernal keratoconjunctivitis may be protective against COVID‐19
title_fullStr Antiviral response in vernal keratoconjunctivitis may be protective against COVID‐19
title_full_unstemmed Antiviral response in vernal keratoconjunctivitis may be protective against COVID‐19
title_short Antiviral response in vernal keratoconjunctivitis may be protective against COVID‐19
title_sort antiviral response in vernal keratoconjunctivitis may be protective against covid‐19
topic Letters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441822/
https://www.ncbi.nlm.nih.gov/pubmed/34390598
http://dx.doi.org/10.1111/all.15048
work_keys_str_mv AT leonardiandrea antiviralresponseinvernalkeratoconjunctivitismaybeprotectiveagainstcovid19
AT rosaniumberto antiviralresponseinvernalkeratoconjunctivitismaybeprotectiveagainstcovid19
AT cavarzeranfabiano antiviralresponseinvernalkeratoconjunctivitismaybeprotectiveagainstcovid19
AT daullphilippe antiviralresponseinvernalkeratoconjunctivitismaybeprotectiveagainstcovid19
AT garriguejeansebastien antiviralresponseinvernalkeratoconjunctivitismaybeprotectiveagainstcovid19
AT paolabrun antiviralresponseinvernalkeratoconjunctivitismaybeprotectiveagainstcovid19